- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Emergence Therapeutics AG
Headquarters: Duisburg, Nordrhein-Westfalen, Germany
Website: N/A
Year Founded: 2019
Status: Acquired
BioCentury | Oct 19, 2023
Regulation
Oct. 18 Quick Takes: FDA approves UCB’s Bimzelx and Zilbrysq
Plus: After appeal, Ardelyx wins approval of kidney therapy, and updates from Mablink, Actym, Syncona, CDER and more
BioCentury | Jun 29, 2023
Product Development
June 29 Quick Takes: Disclosure of impropriety jeopardizes integrity of BioXcel’s trial
Plus: Laekna completes $101M Hong Kong IPO, FDA again rebuffs Alvotech’s Humira biosimilar and updates from Vesalius, Alkermes and Vertex Ventures
BioCentury | Jun 8, 2022
Management Tracks
NIBR’s Marks joins GV as entrepreneur-in-residence
Plus new venture partner and promotions at Arch, and updates from IQVia, Emergence and more
BioCentury | Jan 22, 2022
Data Byte
The largest A rounds of 2021
At least 10 therapeutics companies raised series A rounds of
BioCentury | Dec 7, 2021
Emerging Company Profile
Emergence: creating better ADCs for Nectin-4
German start-up raises €87M series A as it seeks to improve upon Seagen’s Padcev
Items per page:
1 - 5 of 5